No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Hepacivirus* / genetics
-
Hepatitis B Antibodies / blood
-
Hepatitis C Antibodies / blood
-
Hepatitis C, Chronic / diagnosis
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / immunology
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Liver / pathology
-
Liver Cirrhosis / etiology
-
Male
-
Middle Aged
-
Polyethylene Glycols / therapeutic use
-
Practice Guidelines as Topic
-
Protease Inhibitors / therapeutic use
-
Recombinant Proteins
-
Ribavirin / therapeutic use
-
Viral Load
Substances
-
Antiviral Agents
-
Hepatitis B Antibodies
-
Hepatitis C Antibodies
-
Interferon alpha-2
-
Interferon-alpha
-
Protease Inhibitors
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2b
-
peginterferon alfa-2a